gene therapy

Latest Headlines

Latest Headlines

Startup AAVLife sets sights on ataxia with $12M and a novel gene therapy

Parisian biotech AAVLife has come out of stealth with a Versant Ventures-led $12 million A round, looking to advance a gene-deleting therapy that promises to treat the rare and deadly Friedreich's ataxia.

Baxter snaps up its hemophilia partner on the verge of a biotech breakup

Baxter is buying out collaborator Chatham Therapeutics for $70 million, planning to absorb the gene therapy specialist into its growing hemophilia R&D operation as it prepares to separate its drug and device businesses next year.

UPDATED: Baxter breaks in two, creating a $6B biotech business

Baxter International is the latest life sciences player to see better living through mitosis, unveiling a plan to separate its drug development arm from its sprawling med tech business in hopes of helping each grow faster.

OHSU opens new stem cell research center

Oregon Health & Science University is opening a new Center for Embryonic Cell and Gene Therapy to study experimental treatments for Parkinson's disease, multiple sclerosis and a range of other conditions caused by diseased or injured cells in the human body.

Busy Servier grabs an option on Celladon's early-stage diabetes work

A busy Servier wants to explore Celladon's technology to see if there are some small molecule applications to diabetes and other metabolic conditions that warrant clinical development.

Gene therapy regenerates damaged tissue in pigs after heart attack

An experimental gene therapy developed by investigators at the Icahn School of Medicine at Mount Sinai successfully regenerated heart muscle in pigs following a heart attack.

Third Rock puts up $45M for a voyage into gene therapy

Third Rock Ventures has cut the ribbon on its latest startup, pledging $45 million to launch Cambridge, MA's Voyager Therapeutics, a gene therapy biotech with a promising platform for central nervous system treatments.

Early gene therapy results tout a promising treatment for blindness

An experimental gene therapy has restored eyesight to 6 patients in a small Phase I clinical trial in the U.K., exceeding expectations of investigators, according to a new study in The Lancet.

Gene delivery method 'hijacks' tumor blood vessels

In what could become a vast improvement to the delivery of gene therapy within the body, U.S. researchers have developed injectable DNA-carrying viruses that could eventually stop tumor growth or make chemotherapy more effective.

Study: Genes delivered directly to heart stymie heart failure

Researchers at the Icahn School of Medicine at Mount Sinai Hospital used a virus to deliver genes directly to the heart to reverse heart failure, shrinking an enlarged heart and improving its function.